{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:04:32Z","timestamp":1762113872119,"version":"3.37.3"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100017252","name":"Funda\u00e7\u00e3o Am\u00e9lia de Mello","doi-asserted-by":"crossref","award":["Bolsa Pedro Maria Jos\u00e9 de Mello Costa Duarte, 2017"],"award-info":[{"award-number":["Bolsa Pedro Maria Jos\u00e9 de Mello Costa Duarte, 2017"]}],"id":[{"id":"10.13039\/100017252","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100014717","name":"Centro 2020","doi-asserted-by":"crossref","award":["CENTRO-01-0145-FEDER-000008:BrainHealth 2020","CENTRO-01-0246-FEDER-000010"],"award-info":[{"award-number":["CENTRO-01-0145-FEDER-000008:BrainHealth 2020","CENTRO-01-0246-FEDER-000010"]}],"id":[{"id":"10.13039\/501100014717","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-031274","UIDB\/04539\/2020"],"award-info":[{"award-number":["POCI-01-0145-FEDER-031274","UIDB\/04539\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12035-020-02275-9","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T16:02:53Z","timestamp":1611072173000},"page":"2543-2557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3am\u2212\/p+ Mice Modelling Angelman Syndrome Are Attenuated by Adenosine A2A Receptor Blockade"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5468-2647","authenticated-orcid":false,"given":"Ana","family":"Moreira-de-S\u00e1","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-0221","authenticated-orcid":false,"given":"Francisco Q.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5122-1802","authenticated-orcid":false,"given":"Jo\u00e3o P.","family":"Lopes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-3411","authenticated-orcid":false,"given":"Henrique B.","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8671-989X","authenticated-orcid":false,"given":"\u00c2ngelo R.","family":"Tom\u00e9","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-6422","authenticated-orcid":false,"given":"Rodrigo A.","family":"Cunha","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4091-6406","authenticated-orcid":false,"given":"Paula M.","family":"Canas","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"2275_CR1","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1002\/ajmg.a.36058","volume":"161A","author":"LG Mertz","year":"2013","unstructured":"Mertz LG, Christensen R, Vogel I, Hertz JM, Nielsen KB, Gronskov K, Ostergaard JR (2013) Angelman syndrome in Denmark. birth incidence, genetic findings, and age at diagnosis. Am J Med Genet A 161A:2197\u20132203. https:\/\/doi.org\/10.1002\/ajmg.a.36058","journal-title":"Am J Med Genet A"},{"key":"2275_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting K, Williams C, Horsthemke B (2016) Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol 12:584\u2013593. https:\/\/doi.org\/10.1038\/nrneurol.2016.133","journal-title":"Nat Rev Neurol"},{"key":"2275_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0197-70","volume":"15","author":"T Kishino","year":"1997","unstructured":"Kishino T, Lalande M, Wagstaff J (1997) Ube3a\/E6-AP mutations cause Angelman syndrome. Nat Genet 15:70\u201373. https:\/\/doi.org\/10.1038\/ng0197-70","journal-title":"Nat Genet"},{"key":"2275_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/hmg\/8.1.129","volume":"8","author":"P Fang","year":"1999","unstructured":"Fang P, Lev-Lehman E, Tsai TF, Matsuura T, Benton CS, Sutcliffe JS, Christian SL, Kubota T et al (1999) The spectrum of mutations in Ube3a causing Angelman syndrome. Hum Mol Genet 8:129\u2013135. https:\/\/doi.org\/10.1093\/hmg\/8.1.129","journal-title":"Hum Mol Genet"},{"key":"2275_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nn.2327","volume":"12","author":"K Yashiro","year":"2009","unstructured":"Yashiro K, Riday TT, Condon KH, Roberts AC, Bernardo DR, Prakash R, Weinberg RJ, Ehlers MD et al (2009) Ube3a is required for experience-dependent maturation of the neocortex. Nat Neurosci 12:777\u2013783. https:\/\/doi.org\/10.1038\/nn.2327","journal-title":"Nat Neurosci"},{"key":"2275_CR6","doi-asserted-by":"publisher","first-page":"e9842","DOI":"10.1155\/2013\/196848","volume":"2013","author":"AM Hamilton","year":"2013","unstructured":"Hamilton AM, Zito K (2013) Breaking it down: the ubiquitin proteasome system in neuronal morphogenesis. Neural Plast 2013:e9842. https:\/\/doi.org\/10.1155\/2013\/196848","journal-title":"Neural Plast"},{"key":"2275_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.neuroscience.2020.02.017","volume":"445","author":"DC Rotaru","year":"2020","unstructured":"Rotaru DC, Mientjes EJ, Elgersma Y (2020) Angelman Syndrome: From Mouse Models to Therapy. Neuroscience 445:172\u2013189. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.02.017","journal-title":"Neuroscience"},{"key":"2275_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2006","unstructured":"Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, Magenis RE, Moncla A et al (2006) Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A 140:413\u2013418. https:\/\/doi.org\/10.1002\/ajmg.a.31074","journal-title":"Am J Med Genet A"},{"key":"2275_CR9","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1111\/febs.15258","volume":"287","author":"C Maranga","year":"2020","unstructured":"Maranga C, Fernandes TG, Bekman E, Teixeira da Rocha S (2020) Angelman Syndrome: a journey through the brain. FEBS J 287:2154\u20132175. https:\/\/doi.org\/10.1111\/febs.15258","journal-title":"FEBS J"},{"key":"2275_CR10","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1054\/jocn.2000.0753","volume":"8","author":"M Harbord","year":"2001","unstructured":"Harbord M (2001) Levodopa responsive Parkinsonism in adults with Angelman Syndrome. J Clin Neurosci 8:421\u2013422. https:\/\/doi.org\/10.1054\/jocn.2000.0753","journal-title":"J Clin Neurosci"},{"key":"2275_CR11","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/s0896-6273(00)80596-6","volume":"21","author":"YH Jiang","year":"1998","unstructured":"Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, Sweatt JD, Beaudet AL (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21:799\u2013811. https:\/\/doi.org\/10.1016\/s0896-6273(00)80596-6","journal-title":"Neuron"},{"key":"2275_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/nbdi.2001.0463","volume":"9","author":"K Miura","year":"2002","unstructured":"Miura K, Kishino T, Li E, Webber H, Dikkes P, Holmes GL, Wagstaff J (2002) Neurobehavioral and electroencephalographic abnormalities in Ube3A maternal-deficient mice. Neurobiol Dis 9:149\u2013159. https:\/\/doi.org\/10.1006\/nbdi.2001.0463","journal-title":"Neurobiol Dis"},{"key":"2275_CR13","doi-asserted-by":"publisher","first-page":"710943","DOI":"10.1155\/2012\/710943","volume":"2012","author":"NR Jana","year":"2012","unstructured":"Jana NR (2012) Understanding the pathogenesis of Angelman syndrome through animal models. Neural Plast 2012:710943. https:\/\/doi.org\/10.1155\/2012\/710943","journal-title":"Neural Plast"},{"key":"2275_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.nbd.2010.08.002","volume":"40","author":"SA Mulherkar","year":"2010","unstructured":"Mulherkar SA, Jana NR (2010) Loss of dopaminergic neurons and resulting behavioural deficits in mouse model of Angelman syndrome. Neurobiol Dis 40:586\u2013592. https:\/\/doi.org\/10.1016\/j.nbd.2010.08.002","journal-title":"Neurobiol Dis"},{"key":"2275_CR15","doi-asserted-by":"publisher","first-page":"29627","DOI":"10.1074\/jbc.M112.367219","volume":"287","author":"T Steinkellner","year":"2012","unstructured":"Steinkellner T, Yang JW, Montgomery TR, Chen WQ, Winkler MT, Sucic S, Lubec G, Freissmuth M et al (2012) Ca2+\/calmodulin-dependent protein kinase IIalpha (alphaCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem 287:29627\u201329635. https:\/\/doi.org\/10.1074\/jbc.M112.367219","journal-title":"J Biol Chem"},{"key":"2275_CR16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/ejn.12442","volume":"39","author":"V Hayrapetyan","year":"2014","unstructured":"Hayrapetyan V, Castro S, Sukharnikova T, Yu C, Cao X, Jiang YH, Yin HH (2014) Region-specific impairments in striatal synaptic transmission and impaired instrumental learning in a mouse model of Angelman syndrome. Eur J Neurosci 39:1018\u20131025. https:\/\/doi.org\/10.1111\/ejn.12442","journal-title":"Eur J Neurosci"},{"key":"2275_CR17","doi-asserted-by":"publisher","first-page":"10702","DOI":"10.1038\/ncomms10702","volume":"7","author":"J Berrios","year":"2016","unstructured":"Berrios J, Stamatakis AM, Kantak PA, McElligott ZA, Judson MC, Aita M, Rougie M, Stuber GD et al (2016) Loss of UBE3A from TH-expressing neurons suppresses GABA co-release and enhances VTA-NAc optical self-stimulation. Nat Commun 7:10702. https:\/\/doi.org\/10.1038\/ncomms10702","journal-title":"Nat Commun"},{"key":"2275_CR18","doi-asserted-by":"publisher","first-page":"163ra157","DOI":"10.1126\/scitranslmed.3004655","volume":"4","author":"K Egawa","year":"2012","unstructured":"Egawa K, Kitagawa K, Inoue K, Takayama M, Takayama C, Saitoh S, Kishino T, Kitagawa M et al (2012) Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med 4:163ra157. https:\/\/doi.org\/10.1126\/scitranslmed.3004655","journal-title":"Sci Transl Med"},{"key":"2275_CR19","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuroscience.2004.09.013","volume":"130","author":"G Cheron","year":"2005","unstructured":"Cheron G, Servais L, Wagstaff J, Dan B (2005) Fast cerebellar oscillation associated with ataxia in a mouse model of Angelman syndrome. Neuroscience 130:631\u2013637. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.09.013","journal-title":"Neuroscience"},{"key":"2275_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pneurobio.2007.05.001","volume":"83","author":"SN Schiffmann","year":"2007","unstructured":"Schiffmann SN, Fisone G, Moresco R, Cunha RA, Ferr\u00e9 S (2007) Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol 83:277\u2013292. https:\/\/doi.org\/10.1016\/j.pneurobio.2007.05.001","journal-title":"Prog Neurobiol"},{"key":"2275_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1100\/tsw.2007.211","volume":"7","author":"S Ferr\u00e9","year":"2007","unstructured":"Ferr\u00e9 S, Ciruela F, Quiroz C, Luj\u00e1n R, Popoli P, Cunha RA, Agnati LF, Fuxe K et al (2007) Adenosine receptor heteromers and their integrative role in striatal function. ScientificWorldJournal 7:74\u201385. https:\/\/doi.org\/10.1100\/tsw.2007.211","journal-title":"ScientificWorldJournal"},{"key":"2275_CR22","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/jnc.13724","volume":"139","author":"RA Cunha","year":"2016","unstructured":"Cunha RA (2016) How does adenosine control neuronal dysfunction and neurodegeneration? J Neurochem 139:1019\u20131055. https:\/\/doi.org\/10.1111\/jnc.13724","journal-title":"J Neurochem"},{"key":"2275_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s40263-014-0161-7","volume":"28","author":"A Pinna","year":"2014","unstructured":"Pinna A (2014) Adenosine A2A receptor antagonists in Parkinson\u2019s disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued. CNS Drugs 28:455\u2013474. https:\/\/doi.org\/10.1007\/s40263-014-0161-7","journal-title":"CNS Drugs"},{"key":"2275_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11302-020-09694-2","volume":"16","author":"J-F Chen","year":"2020","unstructured":"Chen J-F, Cunha RA (2020) The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson\u2019s disease. Purinergic Signalling. 16:167\u2013174. https:\/\/doi.org\/10.1007\/s11302-020-09694-2","journal-title":"Purinergic Signalling."},{"key":"2275_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ana.24867","volume":"81","author":"N Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves N, Sim\u00f5es AT, Prediger RD, Hirai H, Cunha RA, Pereira de Almeida L (2017) Caffeine alleviates progressive motor deficits in a transgenic mouse model of spinocerebellar ataxia. Ann Neurol 81:407\u2013418. https:\/\/doi.org\/10.1002\/ana.24867","journal-title":"Ann Neurol"},{"key":"2275_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23866","volume":"73","author":"N Gon\u00e7alves","year":"2013","unstructured":"Gon\u00e7alves N, Sim\u00f5es AT, Cunha RA, de Almeida LP (2013) Caffeine and adenosine A2A receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease. Ann Neurol 73:655\u2013666. https:\/\/doi.org\/10.1002\/ana.23866","journal-title":"Ann Neurol"},{"key":"2275_CR27","doi-asserted-by":"publisher","first-page":"7833","DOI":"10.1073\/pnas.1423088112","volume":"112","author":"MP Kaster","year":"2015","unstructured":"Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, Baqi Y, Muller CE et al (2015) Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress. Proc Natl Acad Sci U S A 112:7833\u20137838. https:\/\/doi.org\/10.1073\/pnas.1423088112","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2275_CR28","doi-asserted-by":"publisher","first-page":"12115","DOI":"10.1523\/JNEUROSCI.3343-09.2009","volume":"29","author":"MA Kheirbek","year":"2009","unstructured":"Kheirbek MA, Britt JP, Beeler JA, Ishikawa Y, McGehee DS, Zhuang X (2009) Adenylyl cyclase type 5 contributes to corticostriatal plasticity and striatum-dependent learning. J Neurosci 29:12115\u201312124. https:\/\/doi.org\/10.1523\/JNEUROSCI.3343-09.2009","journal-title":"J Neurosci"},{"key":"2275_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114216","volume":"9","author":"D Rial","year":"2014","unstructured":"Rial D, Castro AA, Machado N, Gar\u00e7\u00e3o P, Gon\u00e7alves FQ, Silva HB, Tom\u00e9 AR, Kofalvi A et al (2014) Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson's disease. PLoS One 9:e114216. https:\/\/doi.org\/10.1371\/journal.pone.0114216","journal-title":"PLoS One"},{"key":"2275_CR30","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/ejn.12851","volume":"41","author":"FQ Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves FQ, Pires J, Pli\u00e1ssova A, Beleza R, Lemos C, Marques JM, Rodrigues RJ, Canas PM et al (2015) Adenosine A2B receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus. Eur J Neurosci 41:878\u2013888. https:\/\/doi.org\/10.1111\/ejn.12851","journal-title":"Eur J Neurosci"},{"key":"2275_CR31","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","volume":"132","author":"N Rebola","year":"2005","unstructured":"Rebola N, Canas PM, Oliveira CR, Cunha RA (2005) Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat. Neuroscience 132:893\u2013903. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.01.014","journal-title":"Neuroscience"},{"key":"2275_CR32","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1523\/jneurosci.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29:14741\u201314751. https:\/\/doi.org\/10.1523\/jneurosci.3728-09.2009","journal-title":"J Neurosci"},{"key":"2275_CR33","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/bph.14771","volume":"176","author":"M Carmo","year":"2019","unstructured":"Carmo M, Gon\u00e7alves FQ, Canas PM, Oses JP, Fernandes FD, Duarte FV, Palmeira CM, Tom\u00e9 AR et al (2019) Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson\u2019s disease. Br J Pharmacol 176:3666\u20133680. https:\/\/doi.org\/10.1111\/bph.14771","journal-title":"Br J Pharmacol"},{"key":"2275_CR34","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1007\/s12035-020-02002-4","volume":"57","author":"AP Fran\u00e7a","year":"2020","unstructured":"Fran\u00e7a AP, Schamne MG, de Souza BS, da Luz SD, Bernardelli AK, Corr\u00eaa T, de Souza IG, Latini A et al (2020) Caffeine consumption plus physical exercise improves behavioral impairments and stimulates neuroplasticity in Spontaneously Hypertensive Rats (SHR): an animal model of attention deficit hyperactivity disorder. Mol Neurobiol 57:3902\u20133919. https:\/\/doi.org\/10.1007\/s12035-020-02002-4","journal-title":"Mol Neurobiol"},{"key":"2275_CR35","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.neuroscience.2006.05.024","volume":"141","author":"GM Cunha","year":"2006","unstructured":"Cunha GM, Canas PM, Oliveira CR, Cunha RA (2006) Increased density and synapto-protective effect of adenosine A2A receptors upon sub-chronic restraint stress. Neuroscience 141:1775\u20131781. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.024","journal-title":"Neuroscience"},{"key":"2275_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jnc.14816","volume":"151","author":"SL Reis","year":"2019","unstructured":"Reis SL, Silva HB, Almeida M, Cunha RA, Sim\u00f5es AP, Canas PM (2019) Adenosine A1 and A2A receptors differently control synaptic plasticity in the mouse dorsal and ventral hippocampus. J Neurochem 151:227\u2013237. https:\/\/doi.org\/10.1111\/jnc.14816","journal-title":"J Neurochem"},{"key":"2275_CR37","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/sj.bjp.0705692","volume":"141","author":"LV Lopes","year":"2004","unstructured":"Lopes LV, Halldner L, Rebola N, Johansson B, Ledent C, Chen JF, Fredholm BB, Cunha RA (2004) Binding of the prototypical adenosine A2A receptor agonist CGS 21680 to the cerebral cortex of adenosine A1 and A2A receptor knockout mice. Br J Pharmacol 141:1006\u20131014. https:\/\/doi.org\/10.1038\/sj.bjp.0705692","journal-title":"Br J Pharmacol"},{"key":"2275_CR38","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1100\/tsw.2009.143","volume":"9","author":"C Quiroz","year":"2009","unstructured":"Quiroz C, Luj\u00e1n R, Uchigashima M, Sim\u00f5es AP, Lerner TN, Borycz J, Kachroo A, Canas PM et al (2009) Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway. ScientificWorldJournal 9:1321\u20131344. https:\/\/doi.org\/10.1100\/tsw.2009.143","journal-title":"ScientificWorldJournal"},{"key":"2275_CR39","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.neurobiolaging.2007.03.025","volume":"29","author":"RJ Rodrigues","year":"2008","unstructured":"Rodrigues RJ, Canas PM, Lopes LV, Oliveira CR, Cunha RA (2008) Modification of adenosine modulation of acetylcholine release in the hippocampus of aged rats. Neurobiol Aging 29:1597\u20131601. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.03.025","journal-title":"Neurobiol Aging"},{"key":"2275_CR40","doi-asserted-by":"publisher","first-page":"e21899","DOI":"10.1371\/journal.pone.0021899","volume":"7","author":"JM Duarte","year":"2012","unstructured":"Duarte JM, Agostinho PM, Carvalho RA, Cunha RA (2012) Caffeine consumption prevents diabetes-induced memory impairment and synaptotoxicity in the hippocampus of NONcZNO10\/LTJ mice. PLoS One 7:e21899. https:\/\/doi.org\/10.1371\/journal.pone.0021899","journal-title":"PLoS One"},{"key":"2275_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nbd.2015.03.030","volume":"79","author":"W Li","year":"2015","unstructured":"Li W, Silva HB, Real J, Wang YM, Rial D, Li P, Payen MP, Zhou Y et al (2015) Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington\u2019s disease models. Neurobiol Dis 79:70\u201380. https:\/\/doi.org\/10.1016\/j.nbd.2015.03.030","journal-title":"Neurobiol Dis"},{"key":"2275_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/s0165-0270(01)00374-0","volume":"108","author":"WW Anderson","year":"2001","unstructured":"Anderson WW, Collingridge GL (2001) The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J Neurosci Methods 108:71\u201383. https:\/\/doi.org\/10.1016\/s0165-0270(01)00374-0","journal-title":"J Neurosci Methods"},{"key":"2275_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1471-4159.2010.07101.x","volume":"116","author":"A Martire","year":"2011","unstructured":"Martire A, Tebano MT, Chiodi V, Ferreira SG, Cunha RA, K\u00f6falvi A, Popoli P (2011) Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission. J Neurochem 116:273\u2013280. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07101.x","journal-title":"J Neurochem"},{"key":"2275_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/s0306-4522(97)00510-1","volume":"84","author":"P Svenningsson","year":"1998","unstructured":"Svenningsson P, Lindskog M, Rognoni F, Fredholm BB, Greengard P, Fisone G (1998) Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84:223\u2013228. https:\/\/doi.org\/10.1016\/s0306-4522(97)00510-1","journal-title":"Neuroscience"},{"key":"2275_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080902","volume":"8","author":"HY Shen","year":"2013","unstructured":"Shen HY, Canas PM, Garcia-Sanz P, Lan JQ, Boison D, Moratalla R, Cunha RA, Chen JF (2013) Adenosine A2A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation. PLoS One 8:e80902. https:\/\/doi.org\/10.1371\/journal.pone.0080902","journal-title":"PLoS One"},{"key":"2275_CR46","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.pharmtox.44.101802.121415","volume":"44","author":"P Svenningsson","year":"2004","unstructured":"Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P (2004) DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269\u2013296. https:\/\/doi.org\/10.1146\/annurev.pharmtox.44.101802.121415","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2275_CR47","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1111\/j.1460-9568.2005.04476.x","volume":"22","author":"AP Strafella","year":"2005","unstructured":"Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O (2005) Corticostriatal functional interactions in Parkinson's disease: a rTMS\/[11C]raclopride PET study. Eur J Neurosci 22:2946\u20132952. https:\/\/doi.org\/10.1111\/j.1460-9568.2005.04476.x","journal-title":"Eur J Neurosci"},{"key":"2275_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrn3469","volume":"14","author":"GM Shepherd","year":"2013","unstructured":"Shepherd GM (2013) Corticostriatal connectivity and its role in disease. Nat Rev Neurosci 14:278\u2013291. https:\/\/doi.org\/10.1038\/nrn3469","journal-title":"Nat Rev Neurosci"},{"key":"2275_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnhum.2016.00317","volume":"10","author":"KD Bunner","year":"2016","unstructured":"Bunner KD, Rebec GV (2016) Corticostriatal dysfunction in Huntington\u2019s disease: the basics. Front Hum Neurosci 10:317. https:\/\/doi.org\/10.3389\/fnhum.2016.00317","journal-title":"Front Hum Neurosci"},{"key":"2275_CR50","doi-asserted-by":"publisher","first-page":"105137","DOI":"10.1016\/j.nbd.2020.105137","volume":"146","author":"A Moreira-de-S\u00e1","year":"2020","unstructured":"Moreira-de-S\u00e1 A, Gon\u00e7alves FQ, Lopes JP, Silva HB, Tom\u00e9 \u00c2R, Cunha RA, Canas PM (2020) Adenosine A2A receptors format long-term depression and memory strategies in a mouse model of Angelman syndrome. Neurobiol Dis. 146:105137. https:\/\/doi.org\/10.1016\/j.nbd.2020.105137","journal-title":"Neurobiol Dis."},{"key":"2275_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nn1845","volume":"10","author":"GM van Woerden","year":"2007","unstructured":"van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila FR, Jiang YH, Elgersma Y et al (2007) Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of \u03b1CaMKII inhibitory phosphorylation. Nat Neurosci 10:280\u2013282. https:\/\/doi.org\/10.1038\/nn1845","journal-title":"Nat Neurosci"},{"key":"2275_CR52","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.1038\/s41598-017-08825-x","volume":"7","author":"HA Born","year":"2017","unstructured":"Born HA, Dao AT, Levine AT, Lee WL, Mehta NM, Mehra S, Weeber EJ, Anderson AE (2017) Strain-dependence of the Angelman Syndrome phenotypes in Ube3A maternal deficiency mice. Sci Rep 7:8451. https:\/\/doi.org\/10.1038\/s41598-017-08825-x","journal-title":"Sci Rep"},{"key":"2275_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13229-018-0231-7","volume":"9","author":"M Sonzogni","year":"2018","unstructured":"Sonzogni M, Wallaard I, Santos SS, Kingma J, du Mee D, van Woerden GM, Elgersma Y (2018) A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Ube3a mutants. Mol Autism 9:47. https:\/\/doi.org\/10.1186\/s13229-018-0231-7","journal-title":"Mol Autism"},{"key":"2275_CR54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/hmg\/ddn117","volume":"17","author":"DH Heck","year":"2008","unstructured":"Heck DH, Zhao Y, Roy S, LeDoux MS, Reiter LT (2008) Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors. Hum Mol Genet 17:2181\u20132189. https:\/\/doi.org\/10.1093\/hmg\/ddn117","journal-title":"Hum Mol Genet"},{"key":"2275_CR55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.bbr.2006.10.004","volume":"176","author":"ML Scattoni","year":"2007","unstructured":"Scattoni ML, Valanzano A, Pezzola A, March ZD, Fusco FR, Popoli P, Calamandrei G (2007) Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington\u2019ssss disease. Behav Brain Res 176:216\u2013221. https:\/\/doi.org\/10.1016\/j.bbr.2006.10.004","journal-title":"Behav Brain Res"},{"key":"2275_CR56","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ana.21313","volume":"63","author":"L Yu","year":"2008","unstructured":"Yu L, Shen HY, Coelho JE, Araujo IM, Huang QY, Day YJ, Rebola N, Canas PM et al (2008) Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms. Ann Neurol 63:338\u2013346. https:\/\/doi.org\/10.1002\/ana.21313","journal-title":"Ann Neurol"},{"key":"2275_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bbr.2012.12.052","volume":"243","author":"HS Huang","year":"2013","unstructured":"Huang HS, Burns AJ, Nonneman RJ, Baker LK, Riddick NV, Nikolova VD, Riday TT, Yashiro K et al (2013) Behavioral deficits in an Angelman syndrome model: effects of genetic background and age. Behav Brain Res 243:79\u201390. https:\/\/doi.org\/10.1016\/j.bbr.2012.12.052","journal-title":"Behav Brain Res"},{"key":"2275_CR58","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuroscience.2019.10.027","volume":"445","author":"R Dutta","year":"2019","unstructured":"Dutta R, Crawley JN (2019) Behavioral evaluation of Angelman syndrome mice at older ages. Neuroscience 445:163\u2013171. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.10.027","journal-title":"Neuroscience"},{"key":"2275_CR59","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI80554","volume":"125","author":"S Silva-Santos","year":"2015","unstructured":"Silva-Santos S, van Woerden GM, Bruinsma CF, Mientjes E, Jolfaei MA, Distel B, Kushner SA, Elgersma Y (2015) Ube3A reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Invest 125:2069\u20132076. https:\/\/doi.org\/10.1172\/JCI80554","journal-title":"J Clin Invest"},{"key":"2275_CR60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.celrep.2015.06.023","volume":"12","author":"J Sun","year":"2015","unstructured":"Sun J, Zhu G, Liu Y, Standley S, Ji A, Tunuguntla R, Wang Y, Claus C et al (2015) Ube3a regulates synaptic plasticity and learning and memory by controlling SK2 channel endocytosis. Cell Rep 12:449\u2013461. https:\/\/doi.org\/10.1016\/j.celrep.2015.06.023","journal-title":"Cell Rep"},{"key":"2275_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000596","volume":"18","author":"G Grasselli","year":"2020","unstructured":"Grasselli G, Boele HJ, Titley HK, Bradford N, van Beers L, Jay L, Beekhof GC, Busch SE et al (2020) SK2 channels in cerebellar Purkinje cells contribute to excitability modulation in motor-learning-specific memory traces. PLoS Biol 18:e3000596. https:\/\/doi.org\/10.1371\/journal.pbio.3000596","journal-title":"PLoS Biol"},{"key":"2275_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/(SICI)1096-9861(19981116)401:2<163::AID-CNE2>3.0.CO;2-D","volume":"401","author":"DL Rosin","year":"1988","unstructured":"Rosin DL, Robeva A, Woodard RL, Guyenet PG, Linden J (1988) Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401:163\u2013186","journal-title":"J Comp Neurol"},{"key":"2275_CR63","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1046\/j.0953-816x.2001.01771.x","volume":"14","author":"M El Yacoubi","year":"2001","unstructured":"El Yacoubi M, Ledent C, Parmentier M, Ongini E, Costentin J, Vaugeois JM (2001) In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261. Eur J Neurosci 14:1567\u20131570. https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01771.x","journal-title":"Eur J Neurosci"},{"key":"2275_CR64","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.brainres.2003.08.055","volume":"992","author":"J Vacas","year":"2003","unstructured":"Vacas J, Fern\u00e1ndez M, Ros M, Blanco P (2003) Adenosine modulation of [Ca2+]i in cerebellar granular cells: multiple adenosine receptors involved. Brain Res. 992:272\u2013280. https:\/\/doi.org\/10.1016\/j.brainres.2003.08.055","journal-title":"Brain Res."},{"key":"2275_CR65","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-l","volume":"13","author":"GE Alexander","year":"1990","unstructured":"Alexander GE, Crutcher MD (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci 13:266\u2013271. https:\/\/doi.org\/10.1016\/0166-2236(90)90107-l","journal-title":"Trends Neurosci"},{"key":"2275_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1155\/NP.2003.107","volume":"10","author":"HJ Groenewegen","year":"2003","unstructured":"Groenewegen HJ (2003) The basal ganglia and motor control. Neural Plast 10:107\u2013120. https:\/\/doi.org\/10.1155\/NP.2003.107","journal-title":"Neural Plast"},{"key":"2275_CR67","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nn.2261","volume":"12","author":"HH Yin","year":"2009","unstructured":"Yin HH, Mulcare SP, Hilario MR, Clouse E, Holloway T, Davis MI, Hansson AC, Lovinger DM et al (2009) Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 12:333\u2013341. https:\/\/doi.org\/10.1038\/nn.2261","journal-title":"Nat Neurosci"},{"key":"2275_CR68","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1172\/JCI83541","volume":"125","author":"CF Bruinsma","year":"2015","unstructured":"Bruinsma CF, Schonewille M, Gao Z, Aronica EM, Judson MC, Philpot BD, Hoebeek FE, van Woerden GM et al (2015) Dissociation of locomotor and cerebellar deficits in a murine Angelman syndrome model. J Clin Invest 125:4305\u20134315. https:\/\/doi.org\/10.1172\/JCI83541","journal-title":"J Clin Invest"},{"key":"2275_CR69","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1471-4159.2004.02887.x","volume":"92","author":"RJ Rodrigues","year":"2005","unstructured":"Rodrigues RJ, Alfaro TM, Rebola N, Oliveira CR, Cunha RA (2005) Co-localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum. J Neurochem 92:433\u2013441. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02887.x","journal-title":"J Neurochem"},{"key":"2275_CR70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12915-020-0739-0","volume":"18","author":"A K\u00f6falvi","year":"2020","unstructured":"K\u00f6falvi A, Moreno E, Cordom\u00ed A, Cai NS, Fern\u00e1ndez-Duenas V, Ferreira SG, Guixa-Gonzalez R, Sanchez-Soto M et al (2020) Control of glutamate release by complexes of adenosine and cannabinoid receptors. BMC Biol 18:9. https:\/\/doi.org\/10.1186\/s12915-020-0739-0","journal-title":"BMC Biol"},{"key":"2275_CR71","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","volume":"20","author":"S Ferr\u00e9","year":"1997","unstructured":"Ferr\u00e9 S, Fredholm BB, Morelli M, Popoli P, Fuxe K (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci 20:482\u2013487","journal-title":"Trends Neurosci"},{"key":"2275_CR72","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.physbeh.2007.05.034","volume":"92","author":"K Fuxe","year":"2007","unstructured":"Fuxe K, Ferr\u00e9 S, Genedani S, Franco R, Agnati LF (2007) Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 92:210\u2013217. https:\/\/doi.org\/10.1016\/j.physbeh.2007.05.034","journal-title":"Physiol Behav"},{"key":"2275_CR73","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11302-013-9364-5","volume":"9","author":"S Cristov\u00e3o-Ferreira","year":"2013","unstructured":"Cristov\u00e3o-Ferreira S, Navarro G, Brugarolas M, Perez-Capote K, Vaz SH, Fattorini G, Conti F, Luis C et al (2013) A1R-A2AR heteromers coupled to Gs and G i\/0 proteins modulate GABA transport into astrocytes. Purinergic Signal 9:433\u2013449. https:\/\/doi.org\/10.1007\/s11302-013-9364-5","journal-title":"Purinergic Signal"},{"key":"2275_CR74","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1172\/JCI61888","volume":"122","author":"TT Riday","year":"2012","unstructured":"Riday TT, Dankoski EC, Krouse MC, Fish EW, Walsh PL, Han JE, Hodge CW, Wightman RM et al (2012) Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest 122:4544\u20134554. https:\/\/doi.org\/10.1172\/JCI61888","journal-title":"J Clin Invest"},{"key":"2275_CR75","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.nbd.2019.104570","volume":"132","author":"FQ Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves FQ, Lopes JP, Silva HB, Lemos C, Silva AC, Goncalves N, Tom\u00e9 AR, Ferreira SG et al (2019) Synaptic and memory dysfunction in a beta-amyloid model of early Alzheimer's disease depends on increased formation of ATP-derived extracellular adenosine. Neurobiol Dis 132:104570. https:\/\/doi.org\/10.1016\/j.nbd.2019.104570","journal-title":"Neurobiol Dis"},{"key":"2275_CR76","doi-asserted-by":"publisher","first-page":"15860","DOI":"10.1038\/ncomms15860","volume":"8","author":"M Assous","year":"2017","unstructured":"Assous M, Kaminer J, Shah F, Garg A, Ko\u00f3s T, Tepper JM (2017) Differential processing of thalamic information via distinct striatal interneuron circuits. Nat Commun 8:15860. https:\/\/doi.org\/10.1038\/ncomms15860","journal-title":"Nat Commun"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02275-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02275-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:27:39Z","timestamp":1621268859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02275-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2275"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02275-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"RA Cunha is a scientific consultant of the Institute for Scientific Information on Coffee (ISIC). All other authors declare no competing financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All animal experiments were conducted in compliance with the ARRIVE guidelines and approved by the Ethical Committee of the Center for Neuroscience and Cell Biology of the University of Coimbra (ORBEA n\u00b0 138-2016\/15072016), following the European Union directive 2010\/63\/EU for the use of animals for scientific purposes, with the certification of the Portuguese National Authority for Animal Health and Well-Being (DGAV).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}